Herbalife (NYSE:HLF - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a "buy" rating to a "strong-buy" rating in a research note issued on Saturday.
A number of other equities research analysts also recently commented on HLF. Citigroup restated a "buy" rating and issued a $21.00 target price (up from $17.00) on shares of Herbalife in a research report on Thursday, February 19th. Maxim Group assumed coverage on Herbalife in a research report on Tuesday, January 6th. They issued a "buy" rating and a $20.00 target price on the stock. Weiss Ratings restated a "hold (c)" rating on shares of Herbalife in a research report on Thursday, January 22nd. Zacks Research upgraded Herbalife from a "hold" rating to a "strong-buy" rating in a research report on Thursday, February 19th. Finally, Mizuho lifted their target price on Herbalife from $13.00 to $15.00 and gave the company a "neutral" rating in a research report on Monday, March 30th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and two have given a Hold rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $17.75.
View Our Latest Report on HLF
Herbalife Stock Up 5.0%
NYSE:HLF opened at $16.99 on Friday. Herbalife has a 52 week low of $6.20 and a 52 week high of $20.40. The company has a market capitalization of $1.76 billion, a P/E ratio of 7.72, a P/E/G ratio of 0.96 and a beta of 0.95. The stock's fifty day moving average is $16.18 and its two-hundred day moving average is $13.57.
Herbalife (NYSE:HLF - Get Free Report) last posted its earnings results on Thursday, February 19th. The company reported $0.45 EPS for the quarter, missing analysts' consensus estimates of $0.48 by ($0.03). Herbalife had a net margin of 4.53% and a negative return on equity of 35.02%. The business had revenue of $1.28 billion during the quarter, compared to analysts' expectations of $1.24 billion. During the same quarter in the prior year, the firm earned $0.36 EPS. Herbalife's revenue for the quarter was up 6.3% compared to the same quarter last year. Sell-side analysts anticipate that Herbalife will post 1.57 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Herbalife
Several institutional investors and hedge funds have recently modified their holdings of HLF. Manatuck Hill Partners LLC increased its holdings in Herbalife by 122.2% during the 3rd quarter. Manatuck Hill Partners LLC now owns 1,000,000 shares of the company's stock worth $8,440,000 after purchasing an additional 550,000 shares during the period. Invenomic Capital Management LP purchased a new stake in Herbalife during the 3rd quarter worth about $3,550,000. Johnson Financial Group LLC increased its holdings in Herbalife by 1,156.1% during the 4th quarter. Johnson Financial Group LLC now owns 414,500 shares of the company's stock worth $5,343,000 after purchasing an additional 381,500 shares during the period. Invesco Ltd. increased its holdings in Herbalife by 60.5% during the 3rd quarter. Invesco Ltd. now owns 763,857 shares of the company's stock worth $6,447,000 after purchasing an additional 287,880 shares during the period. Finally, UBS Group AG increased its holdings in Herbalife by 74.3% during the 3rd quarter. UBS Group AG now owns 658,654 shares of the company's stock worth $5,559,000 after purchasing an additional 280,870 shares during the period.
About Herbalife
(
Get Free Report)
Herbalife Nutrition Ltd. NYSE: HLF operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.
Founded in 1980 by Mark R.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Herbalife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Herbalife wasn't on the list.
While Herbalife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.